LGM

Logos Global Management Portfolio holdings

AUM $1.5B
1-Year Est. Return 197.64%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+197.64%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.5B
AUM Growth
+$488M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
80
New
Increased
Reduced
Closed

Top Buys

1
+$46.6M
2
+$28M
3
+$27.9M
4
IMVT icon
Immunovant
IMVT
+$24.5M
5
MLTX icon
MoonLake Immunotherapeutics
MLTX
+$20.6M

Top Sells

1
+$57M
2
+$47.5M
3
+$21.8M
4
VSTM icon
Verastem
VSTM
+$20.9M
5
PTGX icon
Protagonist Therapeutics
PTGX
+$19.9M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IBIO icon
51
iBio
IBIO
$97.4M
$3.86M 0.26%
+2,000,000
CRVS icon
52
Corvus Pharmaceuticals
CRVS
$1.53B
$3.85M 0.26%
+500,000
ORIC icon
53
Oric Pharmaceuticals
ORIC
$1.31B
$3.68M 0.25%
+450,000
DAWN icon
54
Day One Biopharmaceuticals
DAWN
$1.09B
$2.8M 0.19%
+300,000
PHVS icon
55
Pharvaris
PHVS
$1.84B
$2.77M 0.18%
100,000
-50,000
UNCY icon
56
Unicycive Therapeutics
UNCY
$149M
$2.73M 0.18%
473,563
GUTS icon
57
Fractyl Health
GUTS
$72M
$2.42M 0.16%
1,100,000
+600,000
PTN
58
Palatin Technologies
PTN
$35.6M
$2.15M 0.14%
+140,000
ACRS icon
59
Aclaris Therapeutics
ACRS
$311M
$1.81M 0.12%
600,000
-900,000
VOR icon
60
Vor Biopharma
VOR
$641M
$1.31M 0.09%
+100,000
MREO
61
Mereo BioPharma
MREO
$59M
$771K 0.05%
1,850,000
+1,350,000
SEPN
62
Septerna Inc
SEPN
$1.3B
$657K 0.04%
23,548
-60,000
DBVT
63
DBV Technologies
DBVT
$1.15B
$479K 0.03%
+25,000
NUVB.WS
64
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
$22K ﹤0.01%
66,666
AKRO
65
DELISTED
Akero Therapeutics
AKRO
– –
-1,200,000
ALEC icon
66
Alector
ALEC
$265M
– –
0
APLS icon
67
Apellis Pharmaceuticals
APLS
$2.68B
– –
0
ARVN icon
68
Arvinas
ARVN
$852M
– –
-5,575,000
ATXS
69
DELISTED
Astria Therapeutics
ATXS
– –
-500,000
COGT icon
70
Cogent Biosciences
COGT
$6.31B
– –
-500,000
ESPR icon
71
Esperion Therapeutics
ESPR
$801M
– –
-750,000
IMRX icon
72
Immuneering
IMRX
$322M
– –
-950,000
IMTX icon
73
Immatics
IMTX
$1.39B
– –
0
KROS icon
74
Keros Therapeutics
KROS
$432M
– –
-850,000
LRMR icon
75
Larimar Therapeutics
LRMR
$441M
– –
0
1 2
3
4